Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Infectious Disease

Understanding PAM: The Biological Reality

At a Glance

Primary Amebic Meningoencephalitis (PAM) is a severe, rapidly progressing brain infection caused by the Naegleria fowleri ameba. It occurs when contaminated warm water is forced up the nose. Urgent treatment focuses on aggressive antimicrobial medications and managing dangerous brain swelling.

Finding out that your loved one is fighting a Primary Amebic Meningoencephalitis (PAM) diagnosis is overwhelming. It is a situation that brings sudden, intense fear and a feeling of powerlessness. This page is designed to give you the clear, stabilizing facts about what is happening in the body. While the situation is critical, understanding the biological reality of the condition can help you navigate the coming days and communicate more effectively with the medical team.

What is PAM?

Primary Amebic Meningoencephalitis (PAM) is a rare and life-threatening infection of the brain and the membranes surrounding it [1][2]. It is caused by Naegleria fowleri, a single-celled organism known as a free-living ameba [2].

This organism is “thermophilic,” meaning it thrives in heat [3]. It is commonly found in warm, fresh water such as lakes, rivers, and ponds, as well as in soil [3][4]. In rare cases, it has been found in inadequately treated tap water, well water, splash pads, and wading pools [5][6].

How the Infection Occurs

It is important to understand that you cannot get PAM from drinking water contaminated with the ameba [7]. The infection only happens when water containing the ameba is forced up the nose [7][8]. This typically occurs during:

  • Diving or jumping into warm lakes or rivers [7][4].
  • Recreational water sports [7].
  • Nasal irrigation (such as using a neti pot) or playing on slip-n-slides using untreated tap water [7][9].

Once inside the nose, the ameba attaches to the olfactory neuroepithelium, which is the tissue responsible for your sense of smell [10][11]. From there, it travels along the olfactory nerve fibers, passing through a tiny bone with small holes called the cribriform plate to enter the brain [10][12].

Public Health Warning: If the patient was exposed to a specific body of water, splash pad, or slip-n-slide, it is critical to inform local health authorities and alert any friends or family members who shared the same water source so they can monitor for symptoms.

The Biological Mechanism in the Brain

Once the ameba reaches the brain, it causes a condition known as necrotizing meningoencephalitis [12][13]. This term describes a process of severe tissue death (necrosis) and intense swelling (inflammation) [12][13].

The damage happens through two main pathways:

  1. Direct Destruction: The ameba uses specialized structures called amoebostomes to “bite” and ingest fragments of brain cells, a process called trogocytosis [14][12]. It also releases enzymes (proteases) that actively break down host tissue [15].
  2. Host Response: The body’s immune system recognizes the intruder and launches a massive, often dysregulated inflammatory response [12][16]. While the immune system is trying to help, this intense inflammation contributes significantly to the swelling of the brain [13][16].

Incidence and Rarity

It is vital to keep the rarity of this condition in perspective, even though its severity is extreme. PAM is exceptionally rare, with only a handful of cases reported each year in the United States [1][2].

  • Demographics: The infection disproportionately affects children and young adults, likely due to more frequent participation in recreational water activities [5][6].
  • Geographic Shifts: While historically found in southern states, researchers have noted that the ameba’s range is expanding northward, likely due to rising global temperatures [17][18].
  • Severity: PAM is a “fulminant” infection, meaning it progresses very rapidly [2][1]. Because the symptoms—such as headache, fever, and nausea—closely resemble viral or bacterial meningitis, diagnosis is often delayed [19][2].

The medical team is currently focused on two urgent goals: aggressively treating the infection with a combination of medications and managing the dangerous pressure inside the skull caused by brain swelling [20][2].

Common questions in this guide

How do people catch Primary Amebic Meningoencephalitis?
PAM is contracted when water contaminated with the Naegleria fowleri ameba is forced up the nose, usually during swimming in warm fresh water, water sports, or using unboiled tap water in a neti pot. You cannot get infected by simply drinking contaminated water.
How does the ameba travel from the nose to the brain?
Once inside the nasal passage, the ameba attaches to the tissue responsible for your sense of smell. It then travels along the olfactory nerve fibers, passing through a porous bone situated directly behind the nose to enter the brain.
What exactly does the ameba do to the brain?
The ameba causes rapid tissue destruction by ingesting fragments of brain cells and releasing damaging enzymes. Furthermore, the body launches a massive immune response to fight the intruder, which inadvertently causes severe, life-threatening brain swelling.
Why is PAM so difficult to diagnose early?
The initial signs of PAM, which include headache, fever, and nausea, are virtually identical to those of more common viral or bacterial meningitis. Because PAM is exceptionally rare, these overlapping symptoms frequently cause a delay in getting the correct diagnosis.
Should doctors consult the CDC for a PAM diagnosis?
Yes, your medical team should urgently contact the CDC Emergency Operations Center for a clinical consultation. The CDC has specialized experts on standby to assist local doctors with the immediate, aggressive treatment protocols required for this extremely rare infection.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific combination of medications is currently being administered, and are we aggressively managing brain pressure?
  2. 2.Has our medical team contacted the CDC Emergency Operations Center for a clinical consultation?
  3. 3.If this is confirmed as PAM, what are the next immediate steps in the treatment protocol?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Use of the Novel Therapeutic Agent Miltefosine for the Treatment of Primary Amebic Meningoencephalitis: Report of 1 Fatal and 1 Surviving Case.

    Cope JR, Conrad DA, Cohen N, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016; (62(6)):774-6 doi:10.1093/cid/civ1021.

    PMID: 26679626
  2. 2

    The Brief Case: A Case of Primary Amebic Meningoencephalitis (PAM) after Exposure at a Splash Pad.

    Eger L, Pence MA

    Journal of clinical microbiology 2023; (61(7)):e0126922 doi:10.1128/jcm.01269-22.

    PMID: 37470480
  3. 3

    Prevalence of Naegleria fowleri in Environmental Samples from Northern Part of India.

    Panda A, Khalil S, Mirdha BR, et al.

    PloS one 2015; (10(10)):e0137736 doi:10.1371/journal.pone.0137736.

    PMID: 26484533
  4. 4

    Fatal Case of Naegleria fowleri Primary Amebic Meningoencephalitis from Indoor Surfing Center, Taiwan, 2023.

    Wei HY, Lai YW, Li SY, et al.

    Emerging infectious diseases 2024; (30(9)):1922-1925 doi:10.3201/eid3009.231604.

    PMID: 39174030
  5. 5

    Identification of cysteine protease inhibitors as new drug leads against Naegleria fowleri.

    Zyserman I, Mondal D, Sarabia F, et al.

    Experimental parasitology 2018; (188()):36-41 doi:10.1016/j.exppara.2018.03.010.

    PMID: 29551628
  6. 6

    Challenges and Strategies in Managing Naegleria fowleri-Associated Primary Amoebic Meningoencephalitis in Pakistan: A Case Report.

    Zaman M, Fida T, Haris HM, et al.

    Acta parasitologica 2025; (70(4)):150 doi:10.1007/s11686-025-01091-2.

    PMID: 40622499
  7. 7

    A case of primary amebic meningoencephalitis caused by Naegleria fowleri in Bangladesh.

    Sazzad HMS, Luby SP, Sejvar J, et al.

    Parasitology research 2020; (119(1)):339-344 doi:10.1007/s00436-019-06463-y.

    PMID: 31734864
  8. 8

    Naegleria fowleri: pathogenesis, diagnosis, and treatment options.

    Grace E, Asbill S, Virga K

    Antimicrobial agents and chemotherapy 2015; (59(11)):6677-81 doi:10.1128/AAC.01293-15.

    PMID: 26259797
  9. 9

    Can Amphotericin B-mediated effects be limited using intranasal versus intravenous route?

    Siddiqui R, Yee Ong TY, Maciver S, Khan NA

    Therapeutic delivery 2023; (14(8)):485-490 doi:10.4155/tde-2023-0032.

    PMID: 37691579
  10. 10

    [NAEGLERIA FOWLERI AMOEBA MENINGITIS - REVIEW AND UPDATE].

    Edelman L, Tocut M, Zandman-Goddard G

    Harefuah 2025; (164(4)):256-259.

    PMID: 40257316
  11. 11

    Naegleria fowleri: Sources of infection, pathophysiology, diagnosis, and management; a review.

    Jahangeer M, Mahmood Z, Munir N, et al.

    Clinical and experimental pharmacology & physiology 2020; (47(2)):199-212 doi:10.1111/1440-1681.13192.

    PMID: 31612525
  12. 12

    Enlightening the promising role of nanoparticle-based treatments against Naegleria fowleri-induced primary amoebic meningoencephalitis: A brain-eating disease.

    Jhulki S, Bhowmik B, Pal A

    Microbial pathogenesis 2025; (199()):107234 doi:10.1016/j.micpath.2024.107234.

    PMID: 39701479
  13. 13

    Nanopore sequencing improves the draft genome of the human pathogenic amoeba Naegleria fowleri.

    Liechti N, Schürch N, Bruggmann R, Wittwer M

    Scientific reports 2019; (9(1)):16040 doi:10.1038/s41598-019-52572-0.

    PMID: 31690847
  14. 14

    Characterization of Extracellular Vesicles Secreted by a Clinical Isolate of Naegleria fowleri and Identification of Immunogenic Components within Their Protein Cargo.

    Retana Moreira L, Steller Espinoza MF, Chacón Camacho N, et al.

    Biology 2022; (11(7)) doi:10.3390/biology11070983.

    PMID: 36101365
  15. 15

    Role of cathepsin B of Naegleria fowleri during primary amebic meningoencephalitis.

    Rodríguez-Mera IB, Carrasco-Yépez MM, Vásquez-Moctezuma I, et al.

    Parasitology research 2022; (121(11)):3287-3303 doi:10.1007/s00436-022-07660-y.

    PMID: 36125528
  16. 16

    Identification of Naegleria fowleri proteins linked to primary amoebic meningoencephalitis.

    Jamerson M, Schmoyer JA, Park J, et al.

    Microbiology (Reading, England) 2017; (163(3)):322-332 doi:10.1099/mic.0.000428.

    PMID: 28086072
  17. 17

    Battling brain-eating amoeba: Enigmas surrounding immunity to Naegleria fowleri.

    Moseman EA

    PLoS pathogens 2020; (16(4)):e1008406 doi:10.1371/journal.ppat.1008406.

    PMID: 32324819
  18. 18

    Is Naegleria fowleri an Emerging Parasite?

    Maciver SK, Piñero JE, Lorenzo-Morales J

    Trends in parasitology 2020; (36(1)):19-28 doi:10.1016/j.pt.2019.10.008.

    PMID: 31744676
  19. 19

    Noninvasive diagnostic biomarkers, genomic profiling, and advanced microscopic imaging in the early detection and characterization of Naegleria fowleri infections leading to primary amebic meningoencephalitis (PAM).

    Shaukat A, Khaliq N, Riaz R, et al.

    Annals of medicine and surgery (2012) 2024; (86(4)):2032-2048 doi:10.1097/MS9.0000000000001843.

    PMID: 38576920
  20. 20

    Various brain-eating amoebae: the protozoa, the pathogenesis, and the disease.

    Zhang H, Cheng X

    Frontiers of medicine 2021; (15(6)):842-866 doi:10.1007/s11684-021-0865-2.

    PMID: 34825341

This page provides educational information about the biological mechanisms of Primary Amebic Meningoencephalitis (PAM). It is not a substitute for urgent, professional medical advice from an infectious disease and critical care team.

Get notified when new evidence is published on Primary amebic meningoencephalitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.